[HTML] nature.com

[HTML][HTML] The future of cancer immunotherapy: microenvironment-targeting combinations

YR Murciano-Goroff, AB Warner, JD Wolchok - Cell research, 2020 - nature.com
Immunotherapy holds the potential to induce durable responses, but only a minority of
patients currently respond. The etiologies of primary and secondary resistance to …
被引用次数：577 相关文章

The future of cancer immunotherapy: microenvironment-targeting combinations

YR Murciano-Goroff, AB Warner, JD Wolchok - Cell Research, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> Immunotherapy holds the potential to induce
durable responses, but only a minority of patients currently respond. The etiologies of …

The future of cancer immunotherapy: microenvironment-targeting combinations.

YR Murciano-Goroff, AB Warner, JD Wolchok - Cell Research, 2020 - europepmc.org
Immunotherapy holds the potential to induce durable responses, but only a minority of
patients currently respond. The etiologies of primary and secondary resistance to …

The future of cancer immunotherapy: microenvironment-targeting combinations

YR Murciano-Goroff, AB Warner… - Cell …, 2020 - pubmed.ncbi.nlm.nih.gov
Immunotherapy holds the potential to induce durable responses, but only a minority of
patients currently respond. The etiologies of primary and secondary resistance to …
[HTML] nih.gov

[HTML][HTML] The future of cancer immunotherapy: microenvironment-targeting combinations

YR Murciano-Goroff, AB Warner, JD Wolchok - Cell Research, 2020 - ncbi.nlm.nih.gov
Immunotherapy holds the potential to induce durable responses, but only a minority of
patients currently respond. The etiologies of primary and secondary resistance to …